Modern Diagnostic & Research Centre Board Approves Extension of IPO Proceeds Utilization and Working Capital Allocation
Published on: May 13, 2026, 1:19 p.m. | Source: scanx.trade
Modern Diagnostic & Research Centre Limited held a Board of Directors meeting on May 13, 2026, approving an extension of time for the utilization of net issue proceeds and project completion as per the prospectus. The board also approved the use of General Corporate Purpose funds for working capital requirements. Additionally, the board discussed temporary faults in the company's hardware and software systems, which caused brief shutdowns that were subsequently restored. The disclosures were made in compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
